AirXpanders Revenue and Competitors

Location

$138.9M

Total Funding

Estimated Revenue & Valuation

  • AirXpanders's estimated annual revenue is currently $5.3M per year.(i)
  • AirXpanders's estimated revenue per employee is $310,059
  • AirXpanders's total funding is $138.9M.

Employee Data

  • AirXpanders has 17 Employees.(i)
  • AirXpanders grew their employee count by -6% last year.

AirXpanders's People

NameTitleEmail/Phone
1
Sr. Cost AccountantReveal Email/Phone
2
President & CEOReveal Email/Phone
3
Sr. Production Control LeadReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is AirXpanders?

AirXpanders Inc., founded in 2005, designs, manufactures and markets innovative medical devices to improve breast reconstruction. Headquartered in San Jose, California, AirXpanders is committed to providing patients and surgeons with best-in-class products that are made under strict design and quality standards. The company?s flagship product, the AeroForm Tissue Expander System, is used in patients undergoing two-stage breast reconstruction following mastectomy. The AeroForm Tissue Expander System is the first and only FDA-cleared, patient-controlled and needle-free tissue tissue expander. Instead of requiring weekly visits to the surgeon for saline injections to expand, the AeroForm is gradually filled with carbon dioxide (CO2). Using a wireless dosage controller, the patient independently inflates the expander in the comfort of her own home and is able to control the pace of expansion. AeroForm also has CE Mark and TGA (Australia) approval and is commercially available in Australia. AirXpanders? vision is to be the global leader in reconstructive surgery products and to become the standard of care in two-stage breast reconstruction.

keywords:Biotechnology

$138.9M

Total Funding

17

Number of Employees

$5.3M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

AirXpanders News

2022-04-20 - Breast Tissue Expander Market Size to Grow by USD 246.39 ...

Sientra Inc. Silimed; Specialty Surgical Products Inc. AirXpanders Inc. Find additional highlights on the growth strategies adopted by vendors...

2022-04-17 - Plastic Surgery Device Market Global Development Analysis ...

AirXpanders; Bohus BioTech AB; AbbVie Inc. Merz Pharma GmbH & Co. Merck KGaA; Bonash Medical; Bioha Laboratories; B. Braun Melsungen AG...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.2M17-32%$10M
#2
$0.6M17-69%$4M
#3
$1.5M17N/AN/A
#4
$1.5M17N/AN/A
#5
$1.5M17N/AN/A